dapsone has been researched along with Syndrome in 66 studies
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with PASH syndrome and report about the successful multimodal treatment with infliximab, cyclosporine, and dapsone." | 8.91 | Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone. ( Braun-Falco, M; Goerdt, S; Leverkus, M; Lohse, P; Pfannschmidt, N; Staub, J; Strohal, R, 2015) |
| "The mainstay of leprosy treatment is multidrug treatment (MDT), which contains rifampicin, dapsone and clofazimine." | 8.12 | Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol. ( Budiawan, T; Ferdiana, A; Imaniar, C; Irwanto, A; Krismawati, H; Mieras, L; Pongtiku, A; Singh, P; Wahyuni, T, 2022) |
| "In the Netherlands dapsone is used for the treatment of dermatitis herpetiformis, leprosy and Pneumocystis jiroveci pneumonia and prophylaxis in case of cotrimoxazole allergy." | 7.83 | A lethal case of the dapsone hypersensitivity syndrome involving the myocardium. ( Beuers, U; de Boer, HH; de Vries, HJ; Hoogeveen, RM; Nellen, FJ; Thurlings, RM; van der Bom, T; van der Wal, AC; van Lent, AU; Wind, BS, 2016) |
| "Dapsone syndrome is a potentially fatal hypersensitivity reaction to sulphone." | 7.78 | Dapsone syndrome--first Malaysian paediatric case report. ( Elizawaty, O; Norlijah, O; Thevarajah, S; Zurina, Z, 2012) |
| "Dapsone has potent anti-inflammatory effects, and is used in the treatment of leprosy, cutaneous vasculitis, neutrophilic dermatoses, and dermatitis herpetiformis and other blistering disorders." | 7.75 | Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies. ( Chun, JS; Kim, SJ; Lee, JB; Lee, SC; Won, YH; Yun, SJ, 2009) |
| "Dapsone hypersensitivity syndrome (DHS) is a potentially life-threatening adverse drug reaction consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia." | 7.75 | Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan. ( Chu, CY; Sheen, YS; Tsai, TF; Wang, SH, 2009) |
| "Dapsone syndrome is a rare hypersensitivity reaction to dapsone and is characterized by high fever, papular or exfoliative dermatitis, progressing to liver toxicity and generalized lymphadenopathy, resembling a mononucleosis infection." | 7.73 | Dapsone syndrome with acute renal failure during leprosy treatment: case report. ( Alves-Rodrigues, EN; Fontes, CJ; Ribeiro, LC; Silva, MD; Takiuchi, A, 2005) |
| "We conclude that cholangitis, though unusual, can also form a part of dapsone syndrome." | 7.72 | Dapsone induced cholangitis as a part of dapsone syndrome: a case report. ( Choudhuri, G; Dhingra, S; Itha, S; Kumar, A, 2003) |
| "There has been an increase in the reports of dapsone hypersensitivity syndrome (DHS) in the past few years, coinciding with the introduction of multidrug therapy (MDT) for leprosy world-wide." | 7.71 | Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal. ( Lakshmi, TS; Rao, PN, 2001) |
| "A 34-year-old woman with HIV infection and no other opportunistic infections presented a classic sulfone syndrome, manifested by fever, rash, hemolytic anemia, and fulminant hepatitis due to dapsone hypersensitive reaction, with a fatal outcome." | 7.69 | Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient. ( Baffoe-Bonnie, H; Chalasani, P; Jurado, RL, 1994) |
| "Side-effects of leprosy treatment with dapsone are said to be uncommon, with drug allergy occurring in only one of every several hundred patients treated with dapsone." | 7.68 | Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy. ( Ala, J; Hall, JJ; Reeve, PA, 1992) |
| "Leprosy is a stigmatizing, chronic infection which degenerates the nervous system and often leads to incapacitation." | 5.56 | Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia. ( Irwan, ID; Irwanto, A; Krismawati, H; Liu, H; Liu, J; Maladan, Y; Oktavian, A; Pongtiku, A; Sitanggang, YA; Sun, Y; Tanjung, R; Wahyuni, T; Zhang, F, 2020) |
| "Dapsone therapy was initiated on day +28 at a dose of 100 mg/day for PCP prophylaxis secondary to the patient's history of a sulfonamide allergy." | 5.33 | The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation. ( Abidi, MH; Ibrahim, RB; Kozlowski, JR; Peres, E, 2006) |
| "We describe a patient with PASH syndrome and report about the successful multimodal treatment with infliximab, cyclosporine, and dapsone." | 4.91 | Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone. ( Braun-Falco, M; Goerdt, S; Leverkus, M; Lohse, P; Pfannschmidt, N; Staub, J; Strohal, R, 2015) |
| "The mainstay of leprosy treatment is multidrug treatment (MDT), which contains rifampicin, dapsone and clofazimine." | 4.12 | Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol. ( Budiawan, T; Ferdiana, A; Imaniar, C; Irwanto, A; Krismawati, H; Mieras, L; Pongtiku, A; Singh, P; Wahyuni, T, 2022) |
| "In the Netherlands dapsone is used for the treatment of dermatitis herpetiformis, leprosy and Pneumocystis jiroveci pneumonia and prophylaxis in case of cotrimoxazole allergy." | 3.83 | A lethal case of the dapsone hypersensitivity syndrome involving the myocardium. ( Beuers, U; de Boer, HH; de Vries, HJ; Hoogeveen, RM; Nellen, FJ; Thurlings, RM; van der Bom, T; van der Wal, AC; van Lent, AU; Wind, BS, 2016) |
| "Dapsone syndrome is a potentially fatal hypersensitivity reaction to sulphone." | 3.78 | Dapsone syndrome--first Malaysian paediatric case report. ( Elizawaty, O; Norlijah, O; Thevarajah, S; Zurina, Z, 2012) |
| "Dapsone has potent anti-inflammatory effects, and is used in the treatment of leprosy, cutaneous vasculitis, neutrophilic dermatoses, and dermatitis herpetiformis and other blistering disorders." | 3.75 | Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies. ( Chun, JS; Kim, SJ; Lee, JB; Lee, SC; Won, YH; Yun, SJ, 2009) |
| "Dapsone hypersensitivity syndrome (DHS) is a potentially life-threatening adverse drug reaction consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia." | 3.75 | Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan. ( Chu, CY; Sheen, YS; Tsai, TF; Wang, SH, 2009) |
| "Dapsone syndrome is a rare hypersensitivity reaction to dapsone and is characterized by high fever, papular or exfoliative dermatitis, progressing to liver toxicity and generalized lymphadenopathy, resembling a mononucleosis infection." | 3.73 | Dapsone syndrome with acute renal failure during leprosy treatment: case report. ( Alves-Rodrigues, EN; Fontes, CJ; Ribeiro, LC; Silva, MD; Takiuchi, A, 2005) |
| "We conclude that cholangitis, though unusual, can also form a part of dapsone syndrome." | 3.72 | Dapsone induced cholangitis as a part of dapsone syndrome: a case report. ( Choudhuri, G; Dhingra, S; Itha, S; Kumar, A, 2003) |
| "There has been an increase in the reports of dapsone hypersensitivity syndrome (DHS) in the past few years, coinciding with the introduction of multidrug therapy (MDT) for leprosy world-wide." | 3.71 | Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal. ( Lakshmi, TS; Rao, PN, 2001) |
| " A 71-year-old woman with Wells' syndrome with blood and bone marrow eosinophilia showed a good response to dapsone." | 3.70 | [Eosinophilic cellulitis (Wells syndrome)]. ( Abeck, D; Behrendt, H; Plötz, SG; Ring, J; Simon, HU, 2000) |
| "A male patient who was being treated with oral prednisone for erosive mucocutaneous pemphigus lesions developed fever, jaundice, a rash, and anemia within 2 wk of starting dapsone therapy." | 3.69 | Sulfone syndrome in a patient receiving steroids for pemphigus. ( Barnard, GF; Dagher, RK; Scharf, MJ, 1994) |
| "A 34-year-old woman with HIV infection and no other opportunistic infections presented a classic sulfone syndrome, manifested by fever, rash, hemolytic anemia, and fulminant hepatitis due to dapsone hypersensitive reaction, with a fatal outcome." | 3.69 | Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient. ( Baffoe-Bonnie, H; Chalasani, P; Jurado, RL, 1994) |
| "Side-effects of leprosy treatment with dapsone are said to be uncommon, with drug allergy occurring in only one of every several hundred patients treated with dapsone." | 3.68 | Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy. ( Ala, J; Hall, JJ; Reeve, PA, 1992) |
| "A patient being treated with dapsone developed a hypersensitivity reaction with typical features of the "sulfone syndrome," including fever, malalse, and hepatitis." | 3.67 | Liver involvement in the sulfone syndrome. ( Cattau, EL; Johnson, DA; Kuritsky, JN; Zimmerman, HJ, 1986) |
| "A 79-year-old man with severe generalized pruritus and erythema annulare centrifugum as manifestations of his idiopathic hypereosinophilic syndrome slowly responded to long-term therapy with ketoconazole and dapsone." | 3.67 | Erythema annulare centrifugum as the presenting sign of the hypereosinophilic syndrome: observations on therapy. ( Shelley, ED; Shelley, WB, 1985) |
| "Leprosy is a stigmatizing, chronic infection which degenerates the nervous system and often leads to incapacitation." | 1.56 | Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia. ( Irwan, ID; Irwanto, A; Krismawati, H; Liu, H; Liu, J; Maladan, Y; Oktavian, A; Pongtiku, A; Sitanggang, YA; Sun, Y; Tanjung, R; Wahyuni, T; Zhang, F, 2020) |
| "The swollen hands syndrome is probably due to chronic Mycobacterium leprae tenosynovitis." | 1.35 | [Lepromatous leprosy revealed by a swollen hands syndrome]. ( Boyé, T; Carli, P; Carsuzaa, F; Graffin, B; Landais, C; Leyral, G, 2009) |
| "Dapsone therapy was initiated on day +28 at a dose of 100 mg/day for PCP prophylaxis secondary to the patient's history of a sulfonamide allergy." | 1.33 | The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation. ( Abidi, MH; Ibrahim, RB; Kozlowski, JR; Peres, E, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (27.27) | 18.7374 |
| 1990's | 21 (31.82) | 18.2507 |
| 2000's | 15 (22.73) | 29.6817 |
| 2010's | 7 (10.61) | 24.3611 |
| 2020's | 5 (7.58) | 2.80 |
| Authors | Studies |
|---|---|
| Krismawati, H | 2 |
| Ferdiana, A | 1 |
| Irwanto, A | 2 |
| Budiawan, T | 1 |
| Imaniar, C | 1 |
| Wahyuni, T | 2 |
| Singh, P | 1 |
| Mieras, L | 1 |
| Pongtiku, A | 2 |
| Zhao, Q | 1 |
| Sun, L | 1 |
| Sun, Y | 2 |
| Naisbitt, D | 1 |
| Liu, H | 3 |
| Zhang, F | 3 |
| Soriano, A | 1 |
| Soriano, M | 1 |
| Espinosa, G | 1 |
| Manna, R | 1 |
| Emmi, G | 1 |
| Cantarini, L | 1 |
| Hernández-Rodríguez, J | 1 |
| Irwan, ID | 1 |
| Maladan, Y | 1 |
| Sitanggang, YA | 1 |
| Tanjung, R | 1 |
| Oktavian, A | 1 |
| Liu, J | 1 |
| Kathi, PR | 1 |
| Tama, M | 1 |
| Ehrinpreis, M | 1 |
| Mutchnick, M | 1 |
| Westerhoff, M | 1 |
| Mowers, J | 1 |
| Fontana, RJ | 1 |
| Staub, J | 1 |
| Pfannschmidt, N | 1 |
| Strohal, R | 1 |
| Braun-Falco, M | 1 |
| Lohse, P | 1 |
| Goerdt, S | 1 |
| Leverkus, M | 1 |
| Sauvetre, G | 1 |
| MahÉvas, M | 1 |
| Limal, N | 1 |
| Guillaud, C | 1 |
| Khellaf, M | 1 |
| Bierling, P | 1 |
| Languille, L | 1 |
| Delbos, F | 1 |
| Noizat-Pirenne, F | 1 |
| Michel, M | 1 |
| Godeau, B | 1 |
| Hoogeveen, RM | 1 |
| van der Bom, T | 1 |
| de Boer, HH | 1 |
| Thurlings, RM | 1 |
| Wind, BS | 1 |
| de Vries, HJ | 1 |
| van Lent, AU | 1 |
| Beuers, U | 1 |
| van der Wal, AC | 1 |
| Nellen, FJ | 1 |
| Wang, N | 1 |
| Parimi, L | 1 |
| Landais, C | 1 |
| Graffin, B | 1 |
| Leyral, G | 1 |
| Boyé, T | 1 |
| Carli, P | 1 |
| Carsuzaa, F | 1 |
| Chun, JS | 1 |
| Yun, SJ | 1 |
| Kim, SJ | 1 |
| Lee, SC | 1 |
| Won, YH | 1 |
| Lee, JB | 1 |
| Sheen, YS | 1 |
| Chu, CY | 1 |
| Wang, SH | 1 |
| Tsai, TF | 1 |
| Zurina, Z | 1 |
| Elizawaty, O | 1 |
| Thevarajah, S | 1 |
| Norlijah, O | 1 |
| Hirahara, K | 1 |
| Kano, Y | 1 |
| Asano, Y | 1 |
| Shiohara, T | 1 |
| Nobbe, S | 1 |
| Weibel, L | 1 |
| Kuehne, A | 1 |
| Gobbi, S | 1 |
| Kerl, K | 1 |
| Cozzio, A | 1 |
| Abad Manteca, L | 1 |
| Justo Muradas, I | 1 |
| Pérez Castrillón, JL | 1 |
| Itha, S | 1 |
| Kumar, A | 1 |
| Dhingra, S | 1 |
| Choudhuri, G | 1 |
| Alves-Rodrigues, EN | 1 |
| Ribeiro, LC | 1 |
| Silva, MD | 1 |
| Takiuchi, A | 1 |
| Fontes, CJ | 1 |
| Higuchi, M | 1 |
| Agatsuma, T | 1 |
| Iizima, M | 1 |
| Yamazaki, Y | 1 |
| Saita, T | 1 |
| Ichikawa, T | 1 |
| Kamijo, Y | 1 |
| Arakura, H | 1 |
| Hora, K | 1 |
| Kiyosawa, K | 1 |
| Abidi, MH | 1 |
| Kozlowski, JR | 1 |
| Ibrahim, RB | 1 |
| Peres, E | 1 |
| Sener, O | 1 |
| Doganci, L | 1 |
| Safali, M | 1 |
| Besirbellioglu, B | 1 |
| Bulucu, F | 1 |
| Pahsa, A | 1 |
| Peng, DD | 1 |
| Fang, JL | 1 |
| Wang, H | 1 |
| Wei, L | 1 |
| Zhou, JG | 1 |
| Cai, SQ | 1 |
| Zheng, M | 1 |
| Satta, R | 1 |
| Bolognini, S | 1 |
| Montesu, MA | 1 |
| Cottoni, F | 1 |
| Moschella, SL | 1 |
| Tomecki, KJ | 1 |
| Catalano, CJ | 1 |
| Aram, H | 1 |
| Gan, TE | 1 |
| Van der Weyden, MB | 1 |
| Schiff, BL | 1 |
| Kern, AB | 1 |
| Bercovitch, L | 1 |
| Kromann, NP | 1 |
| Vilhelmsen, R | 1 |
| Stahl, D | 1 |
| Nir, MA | 1 |
| Westfried, M | 1 |
| Dhamija, R | 1 |
| Kumar, D | 1 |
| Khurana, G | 1 |
| Nürnberg, W | 1 |
| Grabbe, J | 1 |
| Czarnetzki, BM | 1 |
| Risse, L | 1 |
| Bernard, P | 1 |
| Brosset, A | 1 |
| Enginger, V | 1 |
| Bedane, C | 1 |
| Bonnetblanc, JM | 1 |
| Stephen, G | 1 |
| George, O | 1 |
| Mathai, D | 1 |
| Kaur, A | 1 |
| Abraham, OC | 1 |
| Hiran, S | 1 |
| Pande, TK | 1 |
| Rizvi, SA | 1 |
| Vishwanathan, KA | 1 |
| Puri, AS | 1 |
| Gupta, R | 1 |
| Ghoshal, UC | 1 |
| Khan, E | 1 |
| Aggarwal, R | 1 |
| Naik, SR | 1 |
| Barnard, GF | 1 |
| Scharf, MJ | 1 |
| Dagher, RK | 1 |
| Chalasani, P | 1 |
| Baffoe-Bonnie, H | 1 |
| Jurado, RL | 1 |
| Noble, A | 1 |
| MacDonald, A | 1 |
| Mok, CC | 1 |
| Lau, CS | 1 |
| McKenna, KE | 1 |
| Robinson, J | 1 |
| Corp, CC | 1 |
| Ghishan, FK | 1 |
| Pavithran, K | 1 |
| Bindu, V | 1 |
| Christiansen, J | 1 |
| Tegner, E | 1 |
| Irestedt, M | 1 |
| Cadnapaphornchai, MA | 1 |
| Saulsbury, FT | 1 |
| Norwood, VF | 1 |
| Plötz, SG | 1 |
| Abeck, D | 1 |
| Behrendt, H | 1 |
| Simon, HU | 1 |
| Ring, J | 1 |
| Rao, PN | 1 |
| Lakshmi, TS | 1 |
| Sneddon, IB | 1 |
| Wilkinson, DS | 1 |
| Lang, PG | 1 |
| Reeve, PA | 1 |
| Ala, J | 1 |
| Hall, JJ | 1 |
| Kraus, A | 1 |
| Jakez, J | 1 |
| Palacios, A | 1 |
| Mohle-Boetani, J | 1 |
| Akula, SK | 1 |
| Holodniy, M | 1 |
| Katzenstein, D | 1 |
| Garcia, G | 1 |
| González Quijada, S | 1 |
| López Lázaro, L | 1 |
| Reinares García, L | 1 |
| Borregón Carretero, SJ | 1 |
| Sastre Varela, J | 1 |
| Estrada Pérez, V | 1 |
| Chan, HL | 1 |
| Lee, KO | 1 |
| Pascual Velasco, F | 1 |
| el Sherif, AI | 1 |
| Bharija, SC | 1 |
| Belhaj, MS | 1 |
| Singh, G | 1 |
| Grayson, ML | 1 |
| Yung, AP | 1 |
| Doherty, RR | 1 |
| Yamamoto, M | 1 |
| Numata, Y | 1 |
| Suehiro, T | 1 |
| Hisatake, K | 1 |
| Kawada, M | 1 |
| Fukatani, Y | 1 |
| Yamano, T | 1 |
| Ohno, F | 1 |
| Lindscheid, KR | 1 |
| Zabel, M | 1 |
| Wille, RC | 1 |
| Morrow, JD | 1 |
| Zagnoli, A | 1 |
| Mottier, D | 1 |
| Sassolas, B | 1 |
| Le Roy, JP | 1 |
| Guillet, G | 1 |
| Jamrozik, K | 1 |
| Fortson, JS | 1 |
| Zone, JJ | 1 |
| Hammond, ME | 1 |
| Groggel, GC | 1 |
| Johnson, DA | 1 |
| Cattau, EL | 1 |
| Kuritsky, JN | 1 |
| Zimmerman, HJ | 1 |
| Shelley, WB | 1 |
| Shelley, ED | 1 |
5 reviews available for dapsone and Syndrome
| Article | Year |
|---|---|
Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide.
Topics: Animals; Autoimmune Diseases; Biological Therapy; Colchicine; Dapsone; Evidence-Based Medicine; Feve | 2020 |
Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.
Topics: Acne Vulgaris; Anti-Infective Agents; Cyclosporine; Dapsone; Dermatologic Agents; Drug Therapy, Comb | 2015 |
A Review on Dapsone Hypersensitivity Syndrome Among Chinese Patients with an Emphasis on Preventing Adverse Drug Reactions with Genetic Testing.
Topics: Adolescent; Adult; Aged; Alleles; Child; China; Dapsone; Drug Hypersensitivity; Drug Substitution; F | 2017 |
[Disulone hypersensitivity syndrome].
Topics: Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Female; Fever; Humans; Middl | 1994 |
The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Dapsone; Drug Hypersensitivity; Humans; Male; Opportunist | 1992 |
61 other studies available for dapsone and Syndrome
| Article | Year |
|---|---|
Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol.
Topics: Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Genetic Testing; Humans; Incidence; Indon | 2022 |
Dapsone hypersensitivity syndrome.
Topics: Dapsone; Drug Hypersensitivity; Humans; Hypersensitivity; Syndrome | 2023 |
Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia.
Topics: Adolescent; Adult; Alleles; Biomarkers; Case-Control Studies; Clofazimine; Dapsone; Drug Hypersensit | 2020 |
Vanishing bile duct syndrome arising in a patient with HIV infection sequentially treated with trimethoprim/sulfamethoxazole and dapsone.
Topics: Anti-Infective Agents; Cholestasis, Intrahepatic; Dapsone; Drug Interactions; Drug Therapy, Combinat | 2020 |
Cutaneous rash and dapsone-induced hypersensitivity syndrome a common manifestation in adult immune thrombocytopenia. Presentation and outcome in 16 cases.
Topics: Adult; Anti-Infective Agents; Dapsone; Drug Hypersensitivity; Exanthema; Female; Humans; Male; Purpu | 2015 |
A lethal case of the dapsone hypersensitivity syndrome involving the myocardium.
Topics: Adult; Dapsone; Drug Hypersensitivity; Fatal Outcome; Female; Heart; Humans; Leprostatic Agents; Lep | 2016 |
[Lepromatous leprosy revealed by a swollen hands syndrome].
Topics: Adult; Anti-Bacterial Agents; Dapsone; Edema; Hand Injuries; Humans; Leprosy, Lepromatous; Male; Myc | 2009 |
Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies.
Topics: Adult; Autoantibodies; Dapsone; Dermatologic Agents; Drug Eruptions; Female; Humans; Hypersensitivit | 2009 |
Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic; Chemical and Drug Induced Liver Injur | 2009 |
Dapsone syndrome--first Malaysian paediatric case report.
Topics: Anti-Infective Agents; Child; Dapsone; Drug Hypersensitivity; Early Diagnosis; Female; Humans; Syndr | 2012 |
Osteonecrosis of the femoral head in a patient with Henoch-Schönlein purpura and drug-induced hypersensitivity syndrome treated with corticosteroids.
Topics: Adult; Anti-Infective Agents; Dapsone; Eosinophilia; Erythema; Exanthema; Femur Head Necrosis; Fever | 2013 |
PLEVA pemphigoides - synchronous features of PLEVA and bullous pemphigoid.
Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Child; Dapsone; Humans; Male; Pemphigoid, Bullous; P | 2013 |
[Dapsona syndrome].
Topics: Adult; Anemia, Hemolytic; Dapsone; Female; Folic Acid Antagonists; Humans; Stomatitis, Aphthous; Syn | 2002 |
Dapsone induced cholangitis as a part of dapsone syndrome: a case report.
Topics: Adult; Cholangitis; Dapsone; Drug Eruptions; Drug Hypersensitivity; Fever; Humans; Hyperbilirubinemi | 2003 |
Dapsone syndrome with acute renal failure during leprosy treatment: case report.
Topics: Acute Kidney Injury; Adult; Clofazimine; Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; | 2005 |
A case of drug-induced hypersensitivity syndrome with multiple organ involvement treated with plasma exchange.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Drug Eruptions; Humans; Male; Middle Aged; Plasma | 2005 |
The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation.
Topics: Anemia, Hemolytic; Chemical and Drug Induced Liver Injury; Dapsone; Dermatitis, Exfoliative; Drug Hy | 2006 |
Severe dapsone hypersensitivity syndrome.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatitis Herpetiformis; Drug Eruptions; D | 2006 |
[Dapsone syndrome: a case report].
Topics: Adult; Dapsone; Drug Eruptions; Humans; Male; Syndrome | 2006 |
Dapsone-induced infectious mononucleosis-like syndrome in a patient with pemphigus vulgaris.
Topics: Adult; Dapsone; Humans; Infectious Mononucleosis; Male; Pemphigus; Syndrome | 2007 |
Amicrobial pustular dermatosis of the folds and Dapsone syndrome on treatment: a case report.
Topics: Dapsone; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisone; Scal | 2008 |
Leprosy today.
Topics: Clofazimine; Dapsone; Disease Models, Animal; Drug Resistance, Microbial; Humans; Leprosy; Mycobacte | 1983 |
Dapsone hypersensitivity. The sulfone syndrome revisited.
Topics: Acne Vulgaris; Adolescent; Anemia, Hemolytic; Chemical and Drug Induced Liver Injury; Dapsone; Drug | 1981 |
Acute febrile neutrophilic dermatosis (Sweet's syndrome). Response to dapsone.
Topics: Acute Disease; Adult; Dapsone; Female; Fever; Humans; Leukocyte Count; Neutrophils; Skin; Skin Disea | 1984 |
Dapsone-induced infectious mononucleosis-like syndrome.
Topics: Dapsone; Drug Therapy, Combination; Eczema; Female; Fluid Therapy; Humans; Hydrocortisone; Infectiou | 1982 |
Sweet's syndrome: report of two atypical cases.
Topics: Biopsy; Blood Sedimentation; Dapsone; Female; Fever; Humans; Leukocytosis; Male; Methylprednisolone; | 1982 |
The dapsone syndrome.
Topics: Adult; Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Female; Humans; Syndr | 1982 |
Hypereosinophilic dermatitis. A distinct manifestation of the hypereosinophilic syndrome with response to dapsone.
Topics: Adult; Dapsone; Dermatitis; Eosinophilia; Humans; Male; Syndrome | 1981 |
Dapsone syndrome.
Topics: Adult; Chemical and Drug Induced Liver Injury; Dapsone; Diagnosis, Differential; Drug Hypersensitivi | 1995 |
Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline.
Topics: Adult; Antigen-Antibody Complex; Complement C3; Dapsone; Drug Combinations; Drug Resistance; Female; | 1995 |
Dapsone syndrome.
Topics: Adult; Dapsone; Drug Eruptions; Drug Hypersensitivity; Female; Fever; Humans; Liver; Syndrome | 1994 |
Dapsone syndrome.
Topics: Adolescent; Adult; Dapsone; Drug Eruptions; Female; Humans; Leprosy, Borderline; Leprosy, Tuberculoi | 1994 |
Hepatic injury in sulfone syndrome: hepatitis or cholestasis?
Topics: Adult; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Dapsone; Drug Hypersensiti | 1995 |
Sulfone syndrome in a patient receiving steroids for pemphigus.
Topics: Aged; Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Drug Therapy, Combinat | 1994 |
Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Chemical and Drug Induced Liver Injury; Dapsone; Drug | 1994 |
Drug-induced hepatotoxicity.
Topics: Antimalarials; Chemical and Drug Induced Liver Injury; Dapsone; Drug Combinations; Drug Eruptions; H | 1996 |
Dapsone syndrome in cutaneous lupus erythematosus.
Topics: Adult; Dapsone; Fatal Outcome; Female; Humans; Leprostatic Agents; Lupus Erythematosus, Cutaneous; M | 1996 |
The dapsone hypersensitivity syndrome occurring in a patient with dermatitis herpetiformis.
Topics: Adolescent; Dapsone; Dermatitis Herpetiformis; Dermatologic Agents; Drug Hypersensitivity; Female; H | 1997 |
The sulfone syndrome complicated by pancreatitis and pleural effusion in an adolescent receiving dapsone for treatment of acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Dapsone; Humans; Male; Mexico; Pancreatitis; Pleural Effusion; Sulfones; | 1998 |
Dapsone syndrome: hepatitis-B infection a risk factor for its development?
Topics: Adult; Amyloidosis; Dapsone; Female; Hepatitis B; Humans; Hypersensitivity; Leprosy; Lichenoid Erupt | 1999 |
Dapsone hypersensitivity syndrome in a patient with cutaneous lupus erythematosus.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Drug Hypersensitivity; Female; Follow-Up Stu | 1999 |
Hypocomplementemic urticarial vasculitis: report of a pediatric case.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Child; Complement System Proteins; Dapsone; Fema | 2000 |
[Eosinophilic cellulitis (Wells syndrome)].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Cellulitis; Dapsone; Diagnosis, Diffe | 2000 |
Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal.
Topics: Adolescent; Adult; Dapsone; Drug Hypersensitivity; Female; Humans; Incidence; India; Leprostatic Age | 2001 |
Subcorneal pustular dermatosis.
Topics: Aged; Dapsone; Diagnosis, Differential; Humans; Male; Middle Aged; Psoriasis; Skin; Skin Diseases, V | 1979 |
Sulfones and sulfonamides in dermatology today.
Topics: Agranulocytosis; Dapsone; Drug Hypersensitivity; Hemolysis; Humans; Kidney Diseases; Methemoglobinem | 1979 |
Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Clofazimine; Dapsone; Drug Eruptions; Dru | 1992 |
Dapsone induced sulfone syndrome and systemic lupus exacerbation.
Topics: Adult; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Sulfones; Syndrome | 1992 |
[Gastrointestinal involvement and the response to dapsone in a case of the urticarial vasculitis syndrome].
Topics: Adult; Chronic Disease; Dapsone; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Human | 1991 |
Tonsillar membrane in the DDS (dapsone) syndrome.
Topics: Dapsone; Drug Eruptions; Female; Heinz Bodies; Humans; Leprosy, Tuberculoid; Middle Aged; Palatine T | 1991 |
[Dapsone syndrome].
Topics: Adult; Dapsone; Drug Hypersensitivity; Female; Humans; Lupus Erythematosus, Cutaneous; Syndrome | 1991 |
Dapsone in Sweet syndrome.
Topics: Adult; Dapsone; Female; Humans; Skin Diseases; Syndrome | 1990 |
Severe dapsone syndrome due to weekly maloprim.
Topics: Adult; Antimalarials; Dapsone; Drug Combinations; Drug Eruptions; Female; Humans; Lymphatic Diseases | 1988 |
[A case of 4-4'-diaminodiphenyl sulfone (DDS) syndrome associated with marked T-cell proliferation and low serum-IgA].
Topics: Adult; Agammaglobulinemia; Dapsone; Female; Hepatitis; Humans; Immunoglobulin A; Leukocytes, Mononuc | 1988 |
[Hypereosinophilia syndrome with cutaneous manifestations, "burning hand" syndrome and increased immunoglobulin levels. Treatment with a combination of DADPS and disodium cromoglycate].
Topics: Aged; Cromolyn Sodium; Dapsone; Drug Therapy, Combination; Eosinophilia; Female; Humans; Hypergammag | 1988 |
Case report: dapsone hypersensitivity syndrome associated with treatment of the bite of a brown recluse spider.
Topics: Anemia, Hemolytic; Dapsone; Drug Hypersensitivity; Fever; Headache; Hepatitis; Humans; Male; Middle | 1988 |
[Relapsing polychondritis beginning like Cogan's syndrome].
Topics: Dapsone; Diagnosis, Differential; Eye Diseases; Female; Hearing Loss, Bilateral; Humans; Middle Aged | 1988 |
Dapsone syndrome occurring in two brothers.
Topics: Adult; Dapsone; Drug Hypersensitivity; Humans; Leprosy; Male; Syndrome | 1986 |
Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone.
Topics: Arthritis; Complement System Proteins; Dapsone; Female; Glomerulonephritis; Humans; Kidney Glomerulu | 1986 |
Liver involvement in the sulfone syndrome.
Topics: Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Female; Fever; Humans; Liver | 1986 |
Erythema annulare centrifugum as the presenting sign of the hypereosinophilic syndrome: observations on therapy.
Topics: Aged; Dapsone; Drug Therapy, Combination; Eosinophilia; Erythema; Humans; Ketoconazole; Male; Syndro | 1985 |